STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
96 hedge funds and large institutions have $555M invested in Stemline Therapeutics, Inc. in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
66% less call options, than puts
Call options by funds: $784K | Put options by funds: $2.28M
Holders
96
Holding in Top 10
3
Calls
$784K
Puts
$2.28M
Top Buyers
| 1 | +$24.3M | |
| 2 | +$16.4M | |
| 3 | +$9.97M | |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$7.66M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$7.66M |
Top Sellers
| 1 | -$8.22M | |
| 2 | -$8.18M | |
| 3 | -$7.66M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
-$6.13M |
| 5 |
Man Group
London,
United Kingdom
|
-$5.82M |